Up to one-third of antibody drugs are nonspecific, study shows

Integral Molecular's Membrane Proteome Array™ reveals pervasive binding of antibody-based drugs to unintended targets

2024-09-17

(Press-News.org) Integral Molecular, a leader in antibody discovery and characterization, has published new research in the journal mAbs, revealing that as many as one-third of antibody-based drugs exhibit nonspecific binding to unintended targets. A serious concern, off-target drug binding is a significant cause of adverse events in patients, with the potential to even cause death. Analysis of antibody off-target binding across different phases of clinical development suggests this to be a major cause of drug attrition. Early specificity testing could improve drug approvals and patient safety.

Learn how antibody developers can use the Membrane Proteome Array™ to assess specificity and de-risk drug development

In this study, Norden et al. present the first empirical assessment of antibody specificity, quantifying the prevalence of off-target binding across the drug pipeline. They accomplished this through retrospective specificity analyses of leading antibody candidates from biopharmaceutical companies and a prospective study of clinically administered antibody drugs (including those that are given to patients in advanced clinical trials, FDA-approved, or withdrawn). The molecules were tested using the Membrane Proteome Array™ (MPA), a cell-based protein array representing the human membrane proteome, that was developed to test specificity and improve drug safety.

Key Findings (Norden et al., mAbs)

18% of the 83 clinically administered antibody drugs tested showed off-target interactions. 22% of the antibody drugs withdrawn from the market, often due to safety issues, showed nonspecific binding. 33% of the 254 lead molecules tested showed nonspecific binding, a predictor of failure in future stages of development. These findings challenge the long-held belief in the absolute specificity of antibodies and underscore the critical need for more rigorous testing.

“Nonspecific drug binding can lead to adverse events or even death,” said Diana Norden, PhD, lead study author. “The presumption that every antibody confers absolute specificity is simply not accurate. New technologies like the MPA provide a detailed assessment of antibody specificity and can significantly de-risk drug development.”

About the Membrane Proteome Array™

Integral Molecular’s Membrane Proteome Array™ is the industry-leading technology for antibody specificity testing used by hundreds of customers worldwide. The MPA assesses binding across ~6,000 proteins, representing the full human membrane proteome. Each protein within the array is individually presented in its biological conformation. MPA processes are ISO 9001 certified, and its specificity data has been accepted by regulatory bodies globally, including the FDA. The MPA is currently under review by the FDA for qualification as an accepted Drug Development Tool.

About Integral Molecular

Integral Molecular (integralmolecular.com) is the industry leader in creating and commercializing transformative technologies that advance the discovery of therapeutics against difficult protein targets. With 20+ years of experience focused on membrane proteins, viruses, and antibodies, Integral Molecular’s technologies have been integrated into the drug discovery pipelines of over 600 biotech and pharmaceutical companies to help discover new therapies for cancer, diabetes, autoimmune disorders, and viral threats such as SARS-CoV-2, Ebola, Zika, and dengue viruses.

Follow Integral Molecular on LinkedIn

Press Contact

Integral Molecular, Inc.

Soma Banik, PhD, Director of Public Relations

215-966-6061

info@integralmolecular.com

www.integralmolecular.com

END

[Attachments] See images for this press release:

Up to one-third of antibody drugs are nonspecific, study shows 2

ELSE PRESS RELEASES FROM THIS DATE:

Shrinking the pint can reduce beer sales by almost 10%

2024-09-17

Reducing the serving size for beer, lager and cider reduces the volume of those drinks consumed in pubs, bars and restaurants, and could be a useful alcohol control measure, according to research published September 17th in the open-access journal PLOS Medicine. Theresa Marteau and colleagues at the University of Cambridge, UK, found that over a short intervention period, venues that removed the pint and offered two third pints instead, sold 10% less beer by volume compared with when pints were available. When wine by the glass is offered in smaller servings, the amount sold ...

Unhealthy behaviors contribute to more coronary artery disease deaths in the poor

2024-09-17

Lower socioeconomic status is associated with higher rates of death from coronary artery disease compared to higher socioeconomic status, and more than half of the disparities can be explained by four unhealthy behaviors. Dr. Yachen Zhu of the Alcohol Research Group, U.S., and Dr. Charlotte Probst of the Centre for Addiction and Mental Health, Canada, report these findings in a new study published September 17th in the open-access journal PLOS Medicine. Coronary artery disease, also known as coronary heart disease or ischemic heart disease, occurs when the arteries supplying the heart cannot deliver enough oxygen-rich blood due to plaque buildup, and is a major cause of death in the ...

Two common surgeries equally effective for treating blinding condition of the eyelid

2024-09-17

Trachomatous trichiasis, a potentially blinding condition where inward-turned eyelashes scratch the front of the eye, can successfully be treated by either of the two most common types of eyelid surgery, according to findings from a large comparison trial funded by the National Institutes of Health. In light of previous, smaller studies, which suggested that one of the commonly used surgery types had poorer outcomes, this study provides reassurance that either technique can treat the condition. The study, published in PLOS Neglected ...

NIH grant supports research into environmental factors regarding male fertility

2024-09-17

DETROIT — A grant from the National Institutes of Health will support ongoing research at Wayne State University investigating the consequences environmental factors may have on fertility in males. The five-year, $3,082,404 grant from the National Institute of Environmental Health Sciences of the National Institutes of Health is led by Richard Pilsner, Ph.D., professor and the Robert J. Sokol, M.D., Endowed Chair of Molecular Obstetrics and Gynecology in the C.S. Mott Center for Human Growth and Development in the department of Obstetrics/Gynecology at Wayne State, and faculty member in the Institute of Environmental ...

Children’s National Hospital selected to lead next-generation BARDA Accelerator Network Special Populations Hub

2024-09-17

WASHINGTON (September 17, 2024) – Children’s National Hospital, widely recognized for its expertise and innovation in pediatric care, has been chosen by the Biomedical Advanced Research and Development Authority (BARDA) to lead the Special Populations Hub in the next generation of the BARDA Accelerator Network. BARDA, is part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The next generation of the BARDA Accelerator Network builds on lessons learned from the first iteration of the network ...

What happens to patients when their GP retires or relocates?

2024-09-17

Norway introduced its Regular GP Scheme was introduced in 2001. This gave all citizens the right to choose a GP in their home municipality and facilitates personal continuity between the doctor and the patient. These types of long-term doctor-patient relationships are associated with reduced use of emergency health services and lower mortality, both internationally and in Norway. A widely discussed Norwegian study from 2022 showed that patients who had the same GP for more than fifteen years had a 25 per cent lower risk of dying compared to patients who had the same GP for one year or less. However, there has been an increasing shortage of GPs in recent years. As of July 2024, just over ...

Cancer cells may be using lipids to hide from the immune system

2024-09-17

Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by planting chemical red flags right on their membranes. Once alerted, the body’s defenses can swoop in, destroying rogue cells before they can do much damage. Lying at the heart of this early warning system are lipids, fatty compounds previously seen by cancer biologists primarily as a fuel source for burgeoning tumors. But now, a new study in Nature demonstrates that one particular lipid type is actually ...

NASA completes spacecraft to transport, support Roman Space Telescope

2024-09-17

The spacecraft bus that will deliver NASA’s Nancy Grace Roman Space Telescope to its orbit and enable it to function once there is now complete after years of construction, installation, and testing. Now that the spacecraft is assembled, engineers will begin working to integrate the observatory’s other major components, including the science instruments and the telescope itself. “They call it a spacecraft bus for a reason — it gets the telescope to where it needs to be ...

University of Health Sciences earns $5.3 million from NIH to boost cancer research, support emerging scientists

2024-09-17

A $5.3 million National Institutes of Health grant awarded to the University of Oklahoma Health Sciences will support advanced cancer research in Oklahoma. The Centers of Biomedical Research Excellence (COBRE) grant is designed to build research capacity and help early-career researchers establish independently funded laboratories. This is the third and final phase of the COBRE grant, which was first awarded in 2012, followed by phase two in 2017. The grant has supported and paralleled the growth of OU Health Stephenson Cancer Center, Oklahoma’s ...

Central America could play troubling new role in cocaine trade

2024-09-17

COLUMBUS, Ohio – For many decades, the coca plant – the main ingredient in cocaine – has been grown almost exclusively in South America. But a new study shows that nearly half of northern Central America appears to be highly suitable for cultivating this lucrative cash crop. Findings showed that 47% of Honduras, Guatemala and Belize have the right climate and soil for commercial coca growing. Most of southern Central America was not suitable. It’s not a hypothetical concern. Researchers began ...

Up to one-third of antibody drugs are nonspecific, study shows

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: